title: Belatacept.
authors: Flavio
authors: F
authors: Vincenti
authors: Argyris
authors: A
authors: Dritselis
authors: Peter
authors: P
authors: Kirkpatrick
mesh_terms: D000069594:Abatacept; D018122:B7-1 Antigen / Q000187:drug effects / Q000378:metabolism; D051940:B7-2 Antigen / Q000187:drug effects / Q000378:metabolism; D018106:CD28 Antigens / Q000378:metabolism; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018122:B7-1 Antigen; D051940:B7-2 Antigen; D018106:CD28 Antigens; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept